Introduction
Pancreaticoduodenectomy (PD) remains the preferred resectional procedure for malignant and benign disorders of the pancreatic head and periampullary region. Although previously associated with high postoperative mortality rates, service centralization, innovations in surgical technique and advances in perioperative management have reduced this to 5 per cent or less in high-volume centres 1, 2 . Despite these measures, morbidity rates after PD remain high at 40-50 per cent 3, 4 . POPF 8 . These risk factors have been aggregated into a fistula risk score, which was validated in independent cohorts 9 . The present authors 10 have previously shown that a raised serum amylase level on the night of surgery (postoperative day (POD) 0) potentially serves as an objective risk factor for the development of clinically relevant POPF, return to the operating theatre and readmission to a critical care environment. This may add objectivity to the subjective intraoperative assessment of risk components for POPF.
C-reactive protein (CRP) has been shown previously to predict postoperative morbidity following oesophageal, gastric and colorectal resections 11, 12 . Although evidence exists to support the value of serum CRP in the prediction of postoperative morbidity following pancreatic resections, it is less clear whether the serial assessment of serum CRP can function as a robust trigger to inform clinical decision-making.
This study sought to determine serum CRP levels in the immediate postoperative period, and the relationship between CRP, POD 0 serum amylase levels and established risk factors for postoperative morbidity following PD, in an effort to optimize risk prediction and individualize patient management.
Methods
In this prospective study all patients underwent either classical or pylorus-preserving PD for malignant or benign disease in the West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK, during a 6-year interval (January 2008 to January 2014) by one of three surgeons. Resectability for malignant disease was classified in accordance with trial inclusion criteria 13 and has been outlined previously 14 .
Data collection
Demographic, pathological and therapeutic data were recorded in a prospective database populated from a combination of electronic patient records, preoperative imaging and anaesthetic charts. Preoperative clinical data included: age, sex, body mass index (BMI), preoperative biliary drainage, and serum investigations including amylase, bilirubin and CRP. The POSSUM physiology score was calculated as an objective measure of co-morbidity and preoperative physiology 15 . Preoperative CT images were assessed to calculate pancreatic duct diameter at the line of transection of the pancreas anterior to the portal vein.
Intraoperative data collection included: American Society of Anesthesiologists status, reconstruction technique and texture of the pancreatic remnant. After surgery the specimens were dichotomized into either pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis or other pathology (including ampullary carcinoma, cholangiocarcinoma, duodenal carcinoma, neuroendocrine tumours and cystic lesions).
Outcome data included length of stay in a critical care environment (either level II or III care) and total length of postoperative hospital stay. Data for readmission to the Glasgow Royal Infirmary were also documented. All postoperative complications were recorded prospectively for up to 30 days after discharge and graded at detailed weekly consensus discussions by the three operating pancreatic surgeons according to the International Study Group of Pancreatic Surgery (ISGPS) classifications and the Dindo-Clavien classification 16 -18 . Mortality at 30 and 90 days was noted.
Operative procedure
Invasive monitoring (central venous, arterial and urinary catheters) and nasogastric tubes were inserted after induction of anaesthesia. All patients received preoperative intravenous antibiotics as prophylaxis for surgical-site infection. A short-acting somatostatin analogue was commenced during surgery and continued for 5 days subcutaneously (octreotide 100 μg), with a proton pump inhibitor continued indefinitely. The operative steps of PD and histological analysis were carried out as described previously 14 . The extent of resection remained constant during this study. With regard to resections for malignant disease, lesions within the uncinate process or those sited medially underwent an artery-first exploration to determine arterial involvement, whereas lesions at the neck underwent early dissection of the hepaticoduodenal ligament to ensure proximal clearance. Short-segment (less than 180 ∘ ) venous involvement was managed by en bloc resection and primary anastomosis if necessary.
Pancreatic transection was performed with scalpel, ultrasonic scalpel or diathermy depending on operator preference. The pancreatic remnant was anastomosed using a dual-layer, duct-to-mucosa technique to either jejunum (pancreaticojejunostomy) or stomach (pancreaticogastrostomy). The choice of anastomosis was based on surgeon preference and not allocated according to risk of postoperative complications. Over the study there was a trend towards increased use of pancreaticogastrostomy formation. Pancreatic duct stents were not used routinely. Absorbable synthetic monofilament sutures (Biosyn TM ; Covidien, Dublin, Ireland) were used for both techniques, with 4/0 sutures for the pancreaticojejunostomy and 3/0 sutures for the pancreaticogastrostomy.
Hepaticojejunostomy and gastrojejunostomy were performed in a standard fashion. At the end of the procedure, one or two non-suction drains were routinely placed adjacent to the pancreatic and biliary anastomosis. The stump of the gastroduodenal artery was not covered routinely.
Perioperative management
In the immediate postoperative period all patients were admitted to the surgeon-led surgical high-dependency unit (level II care). Patients requiring a higher level of care were admitted to the intensive care unit (level III).
Perioperative care was directed by the operating surgeon. Serum laboratory measurements were performed daily from the day before surgery until discharge. Patients were allowed sips of clear fluid from the night of surgery, with oral intake increased as tolerated. Parenteral nutrition was not instituted routinely. Invasive monitoring was ceased based on the patient's clinical progress. Practice at this institution favoured routine drain placement with early removal on the morning of POD 1 based on measurement of serum amylase on POD 0.
Management of suspected POPF included antibiotics, image-guided percutaneous drainage, or surgical exploration with extensive peripancreatic drainage or completion pancreatectomy. Over the study there was a trend towards relaparotomy and establishing extensive peripancreatic drainage if the patient required a return to the operating theatre. IACs were diagnosed on the basis of clinical observations and serum investigations, with confirmation on cross-sectional imaging. Management involved antibiotics, percutaneous drainage and, if necessary, surgical exploration and open drainage. PPH was usually managed with blood transfusion and early angiography, with or without coil embolization or vascular stenting. Endoscopy or relaparotomy was reserved for patients in whom angiography did not provide adequate haemostasis.
Definitions of outcome measures
The upper normal limit for serum amylase concentration at this institute is 100 units/l. The upper normal limit for serum CRP concentration is 10 mg/l. A drain fluid amylase level three times the serum amylase level on or after POD 3 was diagnostic of POPF, in accordance with ISGPS definitions 17 .
IAC was defined as any major intra-abdominal fluid collection found on cross-sectional imaging, associated with any of the following: raised inflammatory marker levels, pyrexia, contiguous drain or wound discharge, or increasing abdominal pain. PPH was diagnosed in accordance with the ISGPS definition 18 . PSC is a composite term capturing POPF, PPH and IAC. Patients who experienced more than one PSC had the event of greater severity recorded as the PSC, and the event of lesser severity recorded in the appropriate complication category (POPF, IAC or PPH). Complications of Dindo-Clavien grade II and above 16 were classed as clinically relevant, as were complications graded as ISGPS grade B or C.
Statistical analysis
Continuous data are presented as median (i.q.r.). The Mann-Whitney U test was used to compare continuous variables between two groups and the Kruskal-Wallis test for comparisons between multiple groups. Categorical variables were compared by means of the χ 2 test. The diagnostic accuracy of serum CRP in predicting adverse postoperative outcomes was assessed by receiver operating characteristic (ROC) curve analysis.
Univariable binary logistic regression analysis, with calculation of odds ratios and 95 per cent c.i., was used to explore the association between demographic, perioperative clinicopathological factors, including POD 0 serum amylase level and the risk of complications, in particular PSCs. Multivariable binary logistic regression analysis was performed including variables showing a significant association on univariable analysis (P < 0⋅050). Backward stepwise regression was used starting with a saturated model; variables with P > 0⋅100 were excluded at each step until no more variables could be excluded. List-wise deletion was performed for variables with missing data. Statistical significance was set at P < 0⋅050. All statistical analysis was performed using SPSS ® version 20.0 (IBM, Armonk, New York, USA).
Results
A total of 230 patients underwent PD in the study interval. Demographic and preoperative details are summarized in Table 1 , and operative and pathology data in Table 2 . None of the patients received preoperative chemoradiotherapy. The median length of drain maintenance was 3 (i.q.r. 2-8 days). 
Postoperative complications
The complication profile of the study cohort is detailed in Table 3 . The overall complication rate was 69⋅1 per cent (Dindo-Clavien grades I-V); the rate of complications graded Dindo-Clavien II and higher was 57⋅8 per cent. Ninety-five patients (41⋅3 per cent) experienced at least one clinically relevant PSC. Twenty-two patients (9⋅6 per cent) had a chyle leak; the majority of these patients also experienced a clinically relevant PSC. Thirteen patients (5⋅7 per cent) developed a biliary fistula, the majority of whom did not require a postoperative intervention. Thirty-one patients (13⋅5 per cent) underwent a relaparotomy; of these, five (2⋅2 per cent) required a completion pancreatectomy. One patient (0⋅4 per cent) returned to the operating theatre for relaparotomy and arrest of haemorrhage from the liver bed, and one patient for a washout and resuturing of a dehisced wound. Twenty-four patients Values in parentheses are 95 per cent c.i. POD, postoperative day; CRP, C-reactive protein.
(10⋅4 per cent) underwent relaparotomy, and establishment of wide peripancreatic drainage for source control of sepsis. Five deaths (2⋅2 per cent) occurred as a consequence of PPH and associated complications, two (0⋅9 per cent) as a result of infected IACs, two (0⋅9 per cent) owing to multiple organ failure and one (0⋅4 per cent) following a postoperative myocardial infarction. Nine of the ten patients who died developed an ISGPF grade C POPF.
C-reactive protein level in relation to outcomes
Serial serum CRP measurements were compared in patients who developed clinically relevant complications versus those who did not experience a complication (Table  S1 , supporting information). Patients who developed a clinically relevant POPF or PSC had a higher median serum CRP level from POD 2. Texture of the pancreatic remnant and serum amylase concentration on POD 0 in relation to the serial expression of serum CRP is illustrated in Fig. S1 (supporting information) .
ROC curve analysis was used to determine threshold values of CRP associated with clinically relevant PSCs and POPF ( Fig. 1 and Table 4) . A CRP of 179 mg/l on POD 2 was most closely associated with clinically relevant PSCs (area under the curve (AUC) 0⋅648, 95 per cent c.i. 0⋅578 to 0⋅719; sensitivity 81⋅5 per cent, specificity 40⋅3 per cent, negative predictive value (NPV) 75⋅3 per cent for PSC; P < 0⋅001), whereas a POD 2 CRP concentration of 230 mg/l was most closely associated with clinically relevant POPF (AUC 0⋅682, 0⋅602 to 0⋅758; sensitivity 61⋅1 per cent, specificity 61⋅9 per cent; P < 0⋅001). For ease of clinical use, a threshold value of 180 mg/l was selected for POD 2 serum CRP concentration.
Patients with a CRP level of 180 mg/l or more on POD 2 were more likely to develop clinically relevant PSCs (P < 0⋅001), POPF (P = 0⋅007), IACs (P = 0⋅002), PPH (P = 0⋅044), and require invasive postoperative intervention (P = 0⋅017) or relaparotomy (P = 0⋅045) ( Table 5 ). There was a trend towards a higher 90-day mortality rate among patients with a POD 2 CRP of 180 mg/l or higher (5⋅7 versus 1 per cent; P = 0⋅132). This higher CRP level was not associated with non-pancreatic complications including cardiorespiratory or wound infections. Increasing severity of PSCs according Dindo-Clavien grade was associated with a rise in median POD 2 serum CRP level (Fig. S2 , supporting information).
Prediction of clinically relevant pancreas-specific complications
The relationships between preoperative characteristics, intraoperative factors, postoperative biochemical markers and the development of clinically relevant PSCs are shown in Table S2 (supporting information). Significant factors in univariable analysis included: small pancreatic duct (P = 0⋅006), soft pancreatic texture (P < 0⋅001), serum amylase level of 130 units/l or more on POD 0 (P < 0⋅001) and serum CRP concentration of 180 mg/l or greater on POD 2 (P < 0⋅001). On multivariable analysis, soft pancreatic texture, amylase level of 130 units/l or more on POD 0 and CRP concentration of 180 mg/l or greater on POD 2 were independent predictors (P = 0⋅011, P = 0⋅001 and P = 0⋅026 respectively in model C) ( Table 6 ).
Predictors of postoperative serum C-reactive protein levels
Univariable logistic regression showed BMI of at least 25 kg/m 2 (P = 0⋅014), pancreatic duct of 3 mm or less (P < 0⋅001), soft pancreatic remnant (P = 0⋅005), non-PDAC/chronic pancreatitis pathology (P = 0⋅001), serum bilirubin level of 250 mmol/l or less (P = 0⋅003) and serum amylase level of 130 units/l or more (P < 0⋅001) to be associated with a CRP concentration of 180 mg/l or greater on POD 2 ( Table S3 , supporting information). In the multivariable model, only small pancreatic duct (P = 0⋅025) and serum amylase level of 130 units/l or more on POD 0 (P = 0⋅003) were independent predictors.
Objective risk stratification
To simplify risk stratification after PD, 214 patients with serum amylase measurements available were grouped into high-risk group (79 patients) had POD 0 serum amylase of at least 130 units/l and POD 2 serum CRP of at least 180 mg/l (Table S4 , supporting information). The highand intermediate-risk groups included significantly more patients with soft textured glands, small pancreatic ducts and other pathology. The risk of clinically relevant PSCs was greater in the high-risk group than in the intermediate-risk group, and there was a trend towards an increase in the 90-day mortality rate (9 versus 2 per cent; P = 0⋅074); there were no deaths within 90 days in the low-risk group (Fig. 2) . Likewise the intermediate-risk group had a significantly worse complication profile than the low-risk group, with a greater frequency of clinically relevant PSCs, POPF and more frequent postoperative invasive interventions. Increasing risk category was associated with hospital stay lasting more than 15 days and critical care stay beyond 7 days.
The low-risk category had a NPV of 86⋅5 per cent for the development of clinically relevant PSCs with a negative likelihood ratio of 0⋅19 compared with the combined intermediate-and high-risk categories. The high-risk category had a positive predictive value of 65⋅8 per cent for the development of clinically relevant PSCs with a positive likelihood ratio of 2⋅35 compared with the rest of the cohort. This risk categorization tool remained a predictor of PSC following stratification by remnant gland texture (Fig. 2) .
Discussion
The present has study shown that, in addition to serum amylase level on POD 0, a raised serum CRP concentration on POD 2 is associated with clinically relevant PSCs. Taken together, these simple serum investigations can stratify the risk of clinically relevant PSCs following PD. Incorporating intraoperative data representing the organ response (as assessed by serum amylase on POD 0) and the host response to the surgical procedure (serum CRP on POD 2), three risk groups were identified with an increasing probability of developing clinically relevant PSCs. Most significantly, this analysis demonstrated a high NPV (86⋅5 per cent) for clinically relevant PSCs among patients in the low-risk category.
The rates of clinically relevant complications and mortality after PD in the present cohort are broadly in keeping with established literature 19 . POPF is not the only determinant of severe morbidity after PD. Overall morbidity or clinically relevant PSCs, which can increase mortality and translate into a prolonged hospital stay, readmission and greater economic burden, should become the focus of risk stratification following PD. PSC represents a useful composite term capturing not only overt POPF but also major consequences of fistulas that were not clinically obvious 20 . The use of serum amylase level on POD 0 as an objective marker to identify patients with a low risk of a clinically relevant POPF (ISGPS grade B/C) has been demonstrated previously 10 . A recent study 21 revealed similar results, with a raised serum amylase level on POD 1 as an independent predictor of POPF. In an effort further to refine risk stratification after PD, the value of postoperative serum CRP was investigated as a tool to identify patients potentially suitable for rapid recovery and safe, early discharge.
The association between a raised postoperative serum CRP level and clinically relevant anastomotic leakage has been demonstrated in colorectal and oesophageal surgery 11, 12 . In a study 22 of serum CRP in patients who had undergone PD, the authors recommended use of a serum CRP cut-off of 140 mg/l on POD 4 to predict general inflammatory complications. Uemura et al. 23 reported that a CRP concentration of 156 mg/l on POD 4 and non-serous fluid in abdominal drains was associated with clinically relevant POPF, whereas Ansorge and co-workers 24 used a combination of drain amylase and raised serum CRP level on POD 3. The latter study provided strong evidence for the ability of serum CRP to predict postoperative complications, yet was limited as intraoperative predictors of POPF, including pancreatic texture and duct size, were not considered.
A risk stratification tool is of clinical value if it has the potential to influence patient management. A risk-stratified perioperative management algorithm could be constructed using the serum amylase level on POD 0 and serum CRP concentration on POD 2. Patients in the low-risk category could be considered suitable for cessation of invasive monitoring, drain removal and rapid step-down from a level II critical care environment. The clinician would also be aware of the increased risk of latent, clinically relevant PSCs in the intermediate-and high-risk groups, informing clinical decision-making beyond POD 2.
The controversy regarding drainage continues to affect the perioperative management of patients undergoing PD. Concern has arisen regarding a standard no-drain policy, notably in a study by Correa-Gallego and co-workers 25 , where the mortality rate increased from 1 to 3 per cent (P = 0⋅02) when routine drainage was eliminated following PD. Furthermore, a recent randomized multicentre trial 26 concluded that elimination of drainage increases the severity and frequency of complications, and may have contributed to increased mortality. If absence of drainage increases mortality risk, a compromise may be that of routine drainage in all PDs followed by selective, early and safe drain removal in order to minimize drain-associated morbidity. Selective drain placement is an alternative strategy; however, this is based on subjective assessment of pancreatic texture 8 .
Pancreatic texture has been identified previously as the principal determinant of a raised CRP level following PD 27 . Independent factors related to a raised level of CRP on POD 2 in the present study were a small pancreatic duct and a serum amylase level of 130 units/l on POD 0. Notably, neither preoperative jaundice nor biliary drainage correlated with postoperative CRP, suggesting that bacteraemia related to biliary tract obstruction or manipulation was not an important factor.
The mechanism underlying hyperamylasaemia after PD remains unclear. Although this may represent extravasation of pancreatic secretions with systemic absorption, postoperative hyperamylasaemia could potentially represent pancreatitis of the normal pancreatic remnant, which subsequently predisposes to anastomotic failure 28 .
Obstruction of the pancreatic duct at the anastomosis owing to haemorrhage, or suture placement, are also potential explanations.
In patients with a high serum amylase level on POD 0, there was a failure of the expected normalization of CRP after 48 h, with the majority of patients who subsequently developed a clinically relevant PSC maintaining a raised CRP level by POD 6. Although this could indicate a proportionate rise in serum CRP in the context of post-PD pancreatitis, an increase in POD 2 serum CRP beyond the 180 mg/l threshold in patients with a low serum amylase level on POD 0 could indicate a disproportionate immune response to the surgical insult of a PD.
Traditionally, a rise in serum CRP concentration is considered to be owing to, rather than the cause of, postoperative complications. Emerging evidence suggests that CRP may play a role in bridging the innate and adaptive immune systems by assisting complement-binding and phagocytosis 29 . High levels depress T-lymphocyte function, and exaggerate the stress response and hyperglycaemia 30 , the latter factors being vital in promoting bacterial growth and development of infective postoperative complications 31 .
Despite the retrospective nature of the analysis, the data generated by examination of routine serum biochemical tests are informative. All patients in this cohort received octreotide as prophylaxis for POPF. Evidence for the value of somatostatin analogues in pancreatic surgery is conflicting 32, 33 . However, based on best available evidence, octreotide is administered as part of the peripancreatectomy management strategy at this and other institutions 34 . Decreasing diameter of the pancreatic duct is associated with increasing risk of clinically relevant POPF and morbidity after PD 8 . However, the size of the present cohort precluded analysis of this factor. A recent study 35 demonstrated that an amylase level below 600 units/l on POD 1 was associated with absence of POPF. This suggests that drain amylase levels on PODs 1 and 3 enhance PSC risk prediction. However, the measurement of drain amylase levels was limited by haemolysis in the majority of patients. This study was unable to provide the POD on which the clinically relevant PSC became apparent, limiting the analysis with regard to the time lag between availability of risk stratification and diagnosis of clinically relevant PSCs. Delayed gastric emptying was recorded poorly before 2012, and was not included in the analysis. Compared with assessment based on preoperative and intraoperative factors alone, the strategy proposed here is limited as scoring requires review at POD 2. However, this reflects an opportune time point for informed, clinically triggered postoperative management decisions regarding drain management, nutrition and critical care step-down. Finally, an external cohort was not used for validation.
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